Different concentrations of various radiopharmaceuticals in the two main liver lobes:: a preliminary study in clinical patients
Different concentrations of various radiopharmaceuticals in the two main liver lobes:: a preliminary study in clinical patients
复制标题
DOI:
10.1007/s00535-005-1617-9
复制
发表时间:
2005-07-01
影响因子:
6.3
通讯作者:
Larsson, SA
中科院分区:
文献类型:
--
作者:
Jacobsson, H;Jonas, E;Larsson, SA
Background. At clinical scintigraphic examinations of the abdomen using single photon emission computed tomography (SPECT), we have observed a different distribution between the left and right main liver lobes of various radiopharmaceuticals. This was studied retrospectively in clinical patients.Methods. Examinations with [I-123]-metaiodobenzylguanidine MIBG; (n = 19), a Tc-99-labelled monoclonal antibody against granulocytes (n = 18), and In-111-pentetreotide (n = 26) were assessed. There was no known history of, or risk factor for liver disease, and all lobes showed a uniform activity distribution. Twenty healthy volunteers underwent consecutive examinations with Tc-99-dimethyliminodiacetic acid (HIDA). The activity ratios between the left and right main liver lobes were calculated from the transverse tomographic (SPECT) sections.Results. The left:right lobar activity ratio for [I-123]-MIBG was (mean +/- SD) 1.25 +/- 0.21 (null hypothesis = 1.00; P < 0.001); for the antibody, acquisition after 3-5h was 0.98 +/- 0.06 (NS) and after 20-24h, 0.99 +/- 0.11 (NS); for In-111-pentetreotide, 0.90 +/- 0.09 (P < 0.001); for Tc-99-HIDA, immediate acquisition, 0.68 +/- 0.12 (P < 0.001) and acquisition at 7min, 0.66 +/- 0.12 (P < 0.001).Conclusions. The differences in tracer uptake between the liver lobes cannot be caused only by differences in blood flow. One explanation of the higher uptake of [I-123]-MIBG by the left lobe may be a greater presence of catecholamines and a higher sympathetic nerve density in this liver portion. Consequently, there may be a functional difference between the two main liver lobes.